Luna Diabetes today took another step forward in advancing its automated insulin delivery patch pump system.
Our sister site, Drug Delivery Business News, reports today that the company closed a $23.6 million Series A financing round to support its insulin delivery technology.
Vensana Capital led the financing round for the San Diego-based company. The Swiss Diabetes Venture Fund, Ascensia Diabetes Care, Winklevoss Capital and other prominent investors also participated.
Funding supports the development of Luna, the company’s automated insulin delivery patch pump system. The company touts Luna as the world’s smallest insulin patch pump, pairing with its fully closed-loop insulin dosing algorithm. Luna Diabetes targets “the vast majority of people” with type 1 and type 2 diabetes who rely on insulin pens.
Get the full story at our sister site, Drug Delivery Business News.
